IRIS - Res&Arch Institutional Research Information System - Research & Archive

CHIASSERINI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.588
EU - Europa 1.975
AS - Asia 1.969
SA - Sud America 389
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 6.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.534
SG - Singapore 904
IT - Italia 445
IE - Irlanda 421
BR - Brasile 334
CN - Cina 326
HK - Hong Kong 318
RU - Federazione Russa 209
DE - Germania 181
VN - Vietnam 179
UA - Ucraina 152
SE - Svezia 117
FI - Finlandia 116
FR - Francia 96
KR - Corea 84
GB - Regno Unito 52
RO - Romania 40
CA - Canada 32
TR - Turchia 31
AT - Austria 29
IN - India 26
AR - Argentina 23
NL - Olanda 23
CH - Svizzera 19
PL - Polonia 19
ZA - Sudafrica 18
BD - Bangladesh 16
IQ - Iraq 15
ES - Italia 13
CZ - Repubblica Ceca 12
ID - Indonesia 12
JP - Giappone 12
BE - Belgio 10
CL - Cile 10
MX - Messico 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 7
EC - Ecuador 6
KE - Kenya 6
SA - Arabia Saudita 6
VE - Venezuela 6
GR - Grecia 4
PY - Paraguay 4
AO - Angola 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
IL - Israele 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BG - Bulgaria 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KI - Kiribati 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NE - Niger 1
NZ - Nuova Zelanda 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 6.972
Salva come PNG Salva come JPEG
Città #
Singapore 624
Dublin 419
Chandler 414
Hong Kong 318
Perugia 212
San Mateo 183
Ashburn 169
Boardman 152
Santa Clara 119
Beijing 100
Altamura 93
Moscow 88
Seoul 83
Medford 81
Princeton 81
Munich 78
Jacksonville 74
Wilmington 70
Lawrence 68
Los Angeles 66
Dong Ket 59
Ho Chi Minh City 53
New York 44
Des Moines 38
Bucharest 34
Andover 31
Piscataway 28
Turku 28
Ann Arbor 27
São Paulo 23
The Dalles 23
Hanoi 22
Redmond 22
Dallas 21
Helsinki 20
Brooklyn 18
Denver 18
Izmir 18
San Paolo di Civitate 18
Frankfurt am Main 17
Chennai 16
Nuremberg 16
Rome 16
Johannesburg 15
Saint Petersburg 15
Vienna 14
Warsaw 14
Phoenix 13
Orem 12
Stockholm 12
Tokyo 12
Lappeenranta 11
Falkenstein 10
Guangzhou 10
Hefei 10
Houston 10
Montreal 10
Norwalk 10
Saint Louis 10
Belo Horizonte 9
Boston 9
Brussels 9
London 9
Chicago 8
Columbus 8
Florence 8
Manchester 8
Olomouc 8
Amsterdam 7
Atlanta 7
Brasília 7
Changsha 7
Curitiba 7
Shanghai 7
São José dos Campos 7
Tashkent 7
Toronto 7
Falls Church 6
Milan 6
Poplar 6
Redwood City 6
Seattle 6
Terni 6
Ankara 5
Campinas 5
Charlotte 5
Lausanne 5
Nairobi 5
Santiago 5
Vicenza 5
Woodbridge 5
Chiajna 4
Fairfield 4
Itajubá 4
Milwaukee 4
Praia Grande 4
Rio de Janeiro 4
Shenyang 4
Utrecht 4
Vancouver 4
Totale 4.541
Salva come PNG Salva come JPEG
Nome #
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 152
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 128
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 118
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 115
3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells 110
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 106
Cerebrospinal fluid biomarkers in Parkinson disease. 105
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 104
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 104
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 102
Protein expression changes induced in murine peritoneal macrophages by Group B Streptococcus 102
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 102
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 101
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 99
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 99
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 97
Crosstalk between long-term sublethal oxidative stress and detrimental inflammation as potential drivers for age-related retinal degeneration 96
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 94
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 94
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 93
Lysosomal enzyme activities in human brain 93
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 89
L’analisi proteomica del carcinoma papillare della tiroide evidenzia modificazioni dello stato ossidoriduttivo e della struttura delle cellule tumorali 88
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 88
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 86
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 84
Mitochondria and the link between neuroinflammation and neurodegeneration. 84
Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis 84
Extracellular Vesicles in Aging: An Emerging Hallmark? 83
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 83
Identification and Partial Characterization of Two Populations of Prostasomes by a Combination of Dynamic Light Scattering and Proteomic Analysis 80
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 80
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. 77
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 77
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies 76
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 75
Origin of α-mannosidase activity in CSF 75
CSF Biomarkers in Parkinson's disease 74
Characterization of Two Populations of Prostasomes by Proteomics and Dynamic Light Scattering 74
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 74
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics 73
Lysosomal enzymes in PD: further evidence is needed. 70
Role of FABP3 as biomarker in Alzheimer's disease and synucleinopathies 70
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 70
A Practical Guide to Immunoassay Method Validation 69
Comprehensive library generation for identification and quantification of endometrial cancer protein biomarkers in cervico-vaginal fluid 69
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 68
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 68
Differential protein expression in glioblastoma cells induced by 3-bromopyruvate 68
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease. 66
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 65
Sistema immunitario e cefalee primarie 65
Proteomic changes induced by Group B Streptococcus in mouse peritoneal macrophages 65
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 65
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study 65
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study 63
Proteomic biomarkers for the detection of endometrial cancer 63
Proteomic analysis of papillary thyroid carcinomas reveals demodulation of signal transduction pathways, increased resistance to oxidative stress and gain of invasive phenotype. 62
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 62
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 62
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression 62
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 61
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 61
Mortalin Inhibition in Experimental Parkinson's Disease 61
PROTEOMIC ANALYSIS OF EXTRACELLULAR VESICLES IN ALZHEIMER’S DISEASE CEREBROSPINAL FLUID 61
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF 60
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients 60
A prostate cancer proteomics database for swath-ms based protein quantification 60
Modelli sperimentali 57
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer 57
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 56
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 56
HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers 55
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 55
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 55
Immunological profile of silent brain infarction and lacunar stroke. 55
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination 55
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 53
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 52
Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset 52
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 51
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia. 51
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 50
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women 50
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 50
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 49
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 48
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization 48
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence. 46
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation 45
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 43
Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina 43
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 42
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 42
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 42
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 41
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease 40
Enhancing mummy ‘palaeobiographies’ though the use of multidisciplinary techniques and approaches 37
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 35
Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment 34
Totale 7.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 20 26 18 48 17 30 67
2021/2022717 8 124 15 30 9 9 4 193 45 47 102 131
2022/20231.391 87 272 16 118 96 141 3 67 535 3 38 15
2023/2024613 32 65 45 17 8 4 113 33 70 22 94 110
2024/20251.625 30 137 59 77 219 104 72 130 297 90 276 134
2025/20261.841 226 247 214 481 491 182 0 0 0 0 0 0
Totale 7.237